Gyre Therapeutics (GYRE) Receivables - Other (2023 - 2025)
Gyre Therapeutics (GYRE) has disclosed Receivables - Other for 6 consecutive years, with $230000.0 as the latest value for Q2 2025.
- On a quarterly basis, Receivables - Other fell 82.31% to $230000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $230000.0, a 82.31% decrease, with the full-year FY2024 number at $5.0 million, up 281.62% from a year prior.
- Receivables - Other was $230000.0 for Q2 2025 at Gyre Therapeutics, up from $200000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $5.0 million in Q4 2024 to a low of $200000.0 in Q1 2025.
- A 3-year average of $1.1 million and a median of $500000.0 in 2024 define the central range for Receivables - Other.
- Peak YoY movement for Receivables - Other: soared 333.33% in 2024, then plummeted 82.31% in 2025.
- Gyre Therapeutics' Receivables - Other stood at $1.2 million in 2023, then surged by 313.42% to $5.0 million in 2024, then crashed by 95.36% to $230000.0 in 2025.
- Per Business Quant, the three most recent readings for GYRE's Receivables - Other are $230000.0 (Q2 2025), $200000.0 (Q1 2025), and $5.0 million (Q4 2024).